BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2026.
World J Gastrointest Oncol. Feb 15, 2026; 18(2): 115944
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.115944
Table 3 Comparative clinical studies evaluating perioperative and oncologic outcomes of propofol vs sevoflurane in gastric cancer surgery
Ref.
Key findings
Method
Wang et al[10]No difference in long-term survival; propofol group had more PONVRetrospective clinical
Zheng et al[18]Fewer inflammatory complications and better postoperative recovery with propofolRetrospective clinical
Wu et al[25]Propofol group showed better long-term survivalRetrospective clinical
Oh et al[26]One-year mortality lower with propofolRetrospective analysis
Ai and Wang[19]Propofol → Higher NK cell activity (immune advantage)Prospective clinical
Song et al[28]No significant difference in AKI incidenceRetrospective matched analysis
Li et al[27]Propofol → Better cognitive and emotional postoperative recoveryClinical study


Write to the Help Desk